J&J nabs accelerated FDA OK for one of their top late-stage drugs
Score one new potential blockbuster OK for J&J.
The FDA offered a quick stamp of approval for their solid tumor drug erdafitinib Friday afternoon, allowing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
